The percentage of CD39+ monocytes is higher in pregnant COVID-19+ patients than in nonpregnant COVID-19+ patients.

The percentage of CD39+ monocytes is higher in pregnant COVID-19+ patients than in nonpregnant COVID-19+ patients.

Current medical guidelines consider pregnant women with COVID-19 to be a high-risk group. Since physiological gestation downregulates the immunological response to maintain "maternal-fetal tolerance", SARS-CoV-2 infection may constitute a potentially threatening condition to both the mothe...

Full description

Bibliographic Details
Main Authors: A Cérbulo-Vázquez, M García-Espinosa, J C Briones-Garduño, L Arriaga-Pizano, E Ferat-Osorio, B Zavala-Barrios, G L Cabrera-Rivera, P Miranda-Cruz, M T García de la Rosa, J L Prieto-Chávez, V Rivero-Arredondo, R L Madera-Sandoval, A Cruz-Cruz, E Salazar-Rios, M E Salazar-Rios, D Serrano-Molina, R C De Lira-Barraza, A H Villanueva-Compean, A Esquivel-Pineda, R Ramirez-Montes de Oca, F Caldiño-Soto, L A Ramírez-García, G Flores-Padilla, O Moreno-Álvarez, G M L Guerrero-Avendaño, C López-Macías
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0264566

Internet

https://doi.org/10.1371/journal.pone.0264566

Similar Items